MedPath
NMPA Approval

Telmisartan and Amlodipine Tablets (Ⅱ)

国药准字H20254435

June 3, 2025

Drug Information

替米沙坦氨氯地平片(Ⅱ)

片剂

每片含替米沙坦40mg与苯磺酸氨氯地平5mg(按C₂₀H₂₅ClN₂O₅计)

化学药品

June 3, 2025

Company Information

Applicant Company

海南省海口市国家高新技术产业开发区科技大道22号海口国科中心D栋7楼

Manufacturing Company

辽宁省大连经济技术开发区大庆路22号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

替米沙坦氨氯地平片(Ⅱ) - NMPA 批准文号 | MedPath